Skandinaviska Enskilda Banken Ab (Publ) Inovio Pharmaceuticals, Inc. Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

  • $21.5 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 11, 2021
SELL
$8.5 - $12.85 $235,450 - $355,945
-27,700 Closed
0 $0
Q3 2020

Nov 12, 2020
SELL
$9.57 - $27.05 $171,303 - $484,195
-17,900 Reduced 39.25%
27,700 $321,000
Q2 2020

Aug 13, 2020
BUY
$7.14 - $31.69 $319,872 - $1.42 Million
44,800 Added 5600.0%
45,600 $1.23 Million
Q1 2020

May 13, 2020
BUY
$2.98 - $14.09 $2,384 - $11,272
800 New
800 $6,000

Others Institutions Holding INO

# of Institutions
10
Shares Held
281K
Call Options Held
0
Put Options Held
0
View Full List

About INOVIO PHARMACEUTICALS, INC.

INO Quotes by TradingView
  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $544M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email